Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

J Viral Hepat. 2014 Dec;21(12):e169-70. doi: 10.1111/jvh.12339. Epub 2014 Sep 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / epidemiology*
  • Humans
  • Male

Substances

  • Antiviral Agents